TKIs

Lancet Oncology Publishes List of Drugs to Avoid for Patients on Tyrosine Kinase Inhibitors

Lancet Oncology, a comprehensive overview of known or suspected drug-drug interactions between tyrosine-kinase inhibitors (Gleevec, Sutent, Stivarga) prescribed for GIST.

By |2019-09-20T14:49:25-04:00August 5th, 2014|Drug Treatment, News|
Go to Top